Clinical Trials Directory

Trials / Completed

CompletedNCT06737367

Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC by CT Images and Pathological Factors

Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC: a Multicenter Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
800 (actual)
Sponsor
Jinling Hospital, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators retrospectively collected the participants with stage I non-small cell lung cancer (NSCLC) patients resected between January 2010 to December 2020 for training and internal validation. The Clinical data, preoperative clinical information, laboratory results and CT images were collected. The investigators also collected the disease-free survival time. On the Deepwise multi-modal research platform, the images were semi-automatically segmented and expanded outward by 3mm to obtain the peritumor tissue. PyRadiomics was used to extract the radiomic features. LASSOcox and rsf were used to select the features. we developed a machine learning-based integrative prognostic model that utilizes radiomic and pathological variables as input using LOOCV framework. And it was further tested on the internal and external cohorts. Discrimination was assessed by using the C-index and area under the receiver operating characteristic curve (AUC), IBS, DCA.

Conditions

Interventions

TypeNameDescription
OTHERCT radiomic analysisRadiomic features of tumor and peritumor tissue

Timeline

Start date
2023-09-01
Primary completion
2024-09-20
Completion
2024-11-11
First posted
2024-12-17
Last updated
2024-12-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06737367. Inclusion in this directory is not an endorsement.